학술논문
Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR)
Document Type
Abstract
Author
Source
In Molecular Genetics and Metabolism February 2024 141(2)
Subject
Language
ISSN
1096-7192